Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Belgium Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20033
20052
20062
20072
20082
20101
20122
20132
20142
20161
20173
20182
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi8
Boehringer Ingelheim3
Daiichi Sankyo3
Bayer2
Bristol-Myers Squibb2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Janssen Scientific Affairs, LLC2
Atrial Fibrillation Network1
CSL Behring1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation29
Stroke5
Arrhythmias, Cardiac4
Atrial Flutter4
Cardiovascular Diseases2
Embolism2
Heart Diseases2
Acute Coronary Syndrome1
Atherosclerosis1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.